Purchases and Sales Made in Q2 2024 in Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX) during Q2 2024. The information is specifically focused on institutions that hold shares of Vaxcyte, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2024
Q2 2024
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-7.21K- 16.49% |
$433K - $568K
|
36.5K
$3.23M
|
|
|
Jul 19, 2024
Q2 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-8.06K- 38.67% |
$484K - $635K
|
12.8K
$1.13M
|
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-11.9K- 24.98% |
$713K - $935K
|
35.6K
$3.15M
|
|
|
Aug 07, 2024
Q2 2024
|
Pier Capital, LLC
Stamford, CT |
SELL
|
- |
-12.4K- 9.75% |
$746K - $978K
|
115K
$10.2M
|
|
|
Aug 13, 2024
Q2 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-13K- 2.74% |
$782K - $1.03M
|
463K
$40.9M
|
|
|
Aug 07, 2024
Q2 2024
|
State Of New Jersey Common Pension Fund D
|
SELL
|
- |
-14K- 26.12% |
$838K - $1.1M
|
39.5K
$3.49M
|
|
|
Dec 03, 2024
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-14.6K- 4.95% |
$874K - $1.15M
|
279K
$24.7M
|
|
|
Jul 23, 2024
Q2 2024
|
Moody Aldrich Partners LLC
|
SELL
|
- |
-18.3K- 15.44% |
$1.1M - $1.44M
|
100K
$8.86M
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-19.7K- 44.93% |
$1.18M - $1.55M
|
24.1K
$2.13M
|
|
|
Aug 14, 2024
Q2 2024
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-20K- 25.0% |
$1.2M - $1.58M
|
60K
$5.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-22.5K- 10.83% |
$1.35M - $1.77M
|
185K
$16.4M
|
|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-26.7K- 69.61% |
$1.6M - $2.1M
|
11.7K
$1.03M
|
|
|
Aug 14, 2024
Q2 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-26.8K- 51.96% |
$1.61M - $2.11M
|
24.8K
$2.19M
|
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-29K- 3.0% |
$1.74M - $2.29M
|
940K
$83M
|
|
|
Aug 13, 2024
Q2 2024
|
Castleark Management LLC
Chicago, IL |
SELL
|
- |
-31.4K- 41.78% |
$1.88M - $2.47M
|
43.7K
$3.86M
|
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-31.5K- 24.95% |
$1.89M - $2.48M
|
94.7K
$8.36M
|
|
|
Aug 14, 2024
Q2 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-45.9K- 2.58% |
$2.76M - $3.61M
|
1.73M
$153M
|
|
|
Aug 12, 2024
Q2 2024
|
Eagle Asset Management Inc
St Petersburg, FL |
SELL
|
- |
-56.4K- 16.66% |
$3.39M - $4.45M
|
282K
$24.9M
|
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-70.2K- 3.63% |
$4.21M - $5.53M
|
1.86M
$165M
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-80.4K- 45.66% |
$4.83M - $6.33M
|
95.7K
$8.45M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-80.8K- 16.47% |
$4.85M - $6.36M
|
410K
$36.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-80.8K- 16.47% |
$4.85M - $6.36M
|
410K
$36.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-86.3K- 6.18% |
$5.18M - $6.8M
|
1.31M
$116M
|
|
|
Aug 14, 2024
Q2 2024
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-87.4K- 23.16% |
$5.25M - $6.88M
|
290K
$25.6M
|
|
|
Aug 15, 2024
Q2 2024
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-100K- 8.78% |
$6.01M - $7.88M
|
1.04M
$91.8M
|
|
|
Aug 14, 2024
Q2 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-101K- 51.31% |
$6.08M - $7.97M
|
96.1K
$8.49M
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-137K- 37.32% |
$8.23M - $10.8M
|
230K
$20.3M
|
|
|
Oct 07, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-138K- 35.94% |
$8.3M - $10.9M
|
246K
$21.7M
|
|
|
Aug 14, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-138K- 35.94% |
$8.3M - $10.9M
|
246K
$21.7M
|
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-156K- 12.62% |
$9.36M - $12.3M
|
1.08M
$95.3M
|
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-215K- 15.08% |
$12.9M - $17M
|
1.21M
$107M
|
|
|
Aug 14, 2024
Q2 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-270K- 25.35% |
$16.2M - $21.3M
|
796K
$70.3M
|
|
|
Aug 13, 2024
Q2 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-326K- 6.63% |
$19.6M - $25.7M
|
4.59M
$406M
|
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-329K- 38.15% |
$19.7M - $25.9M
|
533K
$47.1M
|
|
|
Aug 14, 2024
Q2 2024
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-404K- 33.35% |
$24.3M - $31.9M
|
808K
$71.4M
|
|
|
Aug 14, 2024
Q2 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-613K- 49.42% |
$36.8M - $48.3M
|
627K
$55.4M
|
|
|
Aug 14, 2024
Q2 2024
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
SELL
|
- |
-670K- 24.35% |
$40.2M - $52.8M
|
2.08M
$184M
|